SCHEMBL608489

SCHEMBL608489

[N-]=[N+]=C1C=NC(=O)NC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL11597664 0.94
SCHEMBL5801651 0.69
SCHEMBL4649379 0.65
SCHEMBL884315 0.63
SCHEMBL11277151 0.61
SCHEMBL3077092 0.59
SCHEMBL11243073 0.51
SCHEMBL432911 0.51
SCHEMBL13341976 0.50
SCHEMBL1887298 0.48

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 278 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240271119-A1 METHODS OF PERIPLASMIC PHAGE-ASSISTED CONTINUOUS EVOLUTION THE BROAD INSTITUTE, INC. (US) 2024-08-15 US claimed
EP-4377455-A1 METHODS OF PERIPLASMIC PHAGE-ASSISTED CONTINUOUS EVOLUTION The Broad Institute Inc. (US) 2024-06-05 EP claimed
WO-2023010050-A1 METHODS OF PERIPLASMIC PHAGE-ASSISTED CONTINUOUS EVOLUTION THE BROAD INSTITUTE, INC. (US) 2023-02-02 WO claimed
WO-2021062048-A2 METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIES ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) 2021-04-01 WO claimed
EP-3199630-B1 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS HARVARD COLLEGE (US) 2019-05-08 EP claimed
US-9771574-B2 Apparatus for continuous directed evolution of proteins and nucleic acids PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2017-09-26 US claimed
EP-3199630-A1 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS President and Fellows of Harvard College (US) 2017-08-02 EP claimed
EP-2342336-B1 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS HARVARD COLLEGE (US) 2016-12-14 EP claimed
WO-2016168631-A1 VECTOR-BASED MUTAGENESIS SYSTEM PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-10-20 WO claimed
WO-2016077052-A9 EVOLUTION OF PROTEASES PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-07-21 WO claimed
CN-102370967-A Novel application of IL-1Ra (interleukin-1 receptor antagonist) and tumor treatment medicinal composition kit thereof UNIV SHANGHAI JIAOTONG 2012-03-14 CN claimed
EP-2421523-A1 METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) 2012-02-29 EP claimed
US-20110177495-A1 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2011-07-21 US claimed
EP-2342336-A2 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS President and Fellows of Harvard College (US) 2011-07-13 EP claimed
WO-2010121969-A1 METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2010-10-28 WO claimed
US-20100184707-A1 ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) 2010-07-22 US claimed
EP-2167068-A2 ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS Inserm-Institut National De La Sante Et De La Recherche Medicale (FR) 2010-03-31 EP claimed
WO-2010028347-A2 CONTINUOUS DIRECTED EVOLUTION OF PROTEINS AND NUCLEIC ACIDS PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) 2010-03-11 WO claimed
WO-2009004082-A2 ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2009-01-08 WO claimed
EP-2011491-A1 Anticonvulsive pharmaceutical compositions INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2009-01-07 EP claimed